n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n
U.S. Diagnostics Market
Dublin, January 23, 2024 (GLOBE NEWSWIRE) — The “U. S. Market, Competition, Prognosis, and Diagnostic Opportunities” is expected to be a global global market. “U. S. Airport, 2018-2028” was added to the ResearchAndMarkets. com offering.
The U. S. diagnostics market is expected to be the largest in the world. The U. S. is expected to witness significant expansion between 2018 and 2028, developing at a compound annual expansion rate (CAGR) of 8. 93% through 2028, according to a comprehensive market analysis. Valued at $35. 66 billion in 2022, the market expansion is driven through a variety of factors, adding advancements in diagnostic technologies and increased personalized medical care.
Growing Demand for Advanced Diagnostics in the United States
There has been an increase in the use of diagnostic tests due to the growing burden of infectious and chronic diseases. An increasing number of healthcare providers are adopting automated platforms that offer more accurate, reliable, and faster diagnostic procedures. The recent pandemic has highlighted the importance of immediate and accurate diagnosis in infectious disease management and outbreak control. In addition, the adoption of newer technologies, such as next-generation sequencing, liquid biopsy, and AI-based diagnostic responses, has further strengthened the imperative role of diagnostics in trendy healthcare.
Technological Innovations Support Market Growth
The integration of complex technologies such as synthetic intelligence (AI) and device learning is revolutionizing the diagnostic landscape in the United States. These inventions contribute to the early detection of diseases and the implementation of personalized remedy plans. Trials of care (POCS) have been instrumental in improving the effectiveness of patient management strategies. The virtual transformation of pathology, coupled with the advent of virtual pathology platforms and their growing adoption in the United States, is facilitating innovations in the quality and timeliness of diagnosis.
Industry Insights: Regional dominance and market performance The Northeast region is expected to dominate its dominance in the United States diagnostics market due to its strong healthcare infrastructure, notable healthcare spending, and presence of industry-leading companies. of the call for product types, as they are a must-have in a multitude of diagnostic applications. Infectious disease verification is expected to dominate the verification types segment, owing to the increased need for immediate and accurate diagnostic equipment in recent mild infectious disease outbreaks.
Product Types: Reagents are used in a wide variety of diagnostic platforms, such as immunodiagnostics and molecular diagnostics.
Type of Test: Infectious Disease Testing is emerging as the largest segment as technological advancements lead to more efficient testing methods.
End-user: Hospitals, public laboratories and diagnostic centers, the main users of the diagnostics market.
With the healthcare landscape continually evolving, diagnostic companies are challenged to innovate and provide affordable and efficient diagnostic solutions. The industry faces hurdles such as the complexity of reimbursement scenarios, which could impact demand. Nonetheless, the soaring development of user-friendly diagnostic devices and the incorporation of digital pathology are setting the stage for a more connected and efficient healthcare system in the United States.
In essence, the United States Diagnostics Market is on a trajectory of growth and innovation, with a focus on enhancing the accessibility and quality of healthcare services through cutting-edge diagnostic solutions. As the industry moves forward, it is expected to continue making strides in improving patient outcomes and disease management strategies.Key Attributes:
Report Attribute
Details
No. of Pages
84
Forecast period
2022 – 2028
Estimated market (USD) in 2022
$35. 66 billion
Expected market (USD) until 2028
$59. 9 billion
Compound Annual Growth Rate
9,1%
Regions Covered
UNITED STATES
Report Scope: In this report, the United States Diagnostics market has been segmented into the following categories, in addition to the trends that are also detailed below: United States Diagnostics Market, by Product Type:
Reagents
Instruments
Software & Services
United States Diagnostic Market, by Test Type:
Infectious Disease Testing
Lipid Panel
Metabolic Panel
Fro
U. S. Diagnostic Market, Through Technique:
Immunodiagnosis
Clinical Techniques
Molecular diagnostics
Tissue Diagnostics
Others
US Diagnostic Market, Usability:
Reusable
Disposable
U. S. Diagnostics Market, via App:
Infectious Diseases Cancer
Sexually Transmitted Diseases
Fro
U. S. Diagnostics Market, Through End User:
hospitals
Public Laboratories
Diagnostic Centers
Point-of-Care Testing Centers
Private or Laboratory
Fro
U. S. Diagnostics Market by Region:
Northeast Region
Midwest Region
Western Region
Southern Region
Company Profiles
Abbott Laboratories, Inc.
Danaher Company
Thermo Fisher Scientific, Inc.
Johnson
Ortho-Clinical Diagnostics, Inc.
Becton, Dickinson, and Company
Bio-Rad Laboratories, Inc.
Roche Diagnostics Corporation
Siemens Medical Solutions USA, Inc.
Biomerieux Inc.
For more information on this report, https://www. researchandmarkets. com/r/x5pkm1
About ResearchAndMarkets. com ResearchAndMarkets. com is the world’s leading source of foreign market research and market insight reports. We provide you with the latest knowledge on foreign and regional markets, key industries, largest companies, new products and the latest trends.
Attach
U.S. Diagnostics Market